Transcranial Magnetic Stimulation (TMS) Chair
Contract Opportunity Analysis
The Department of Defense, through the U.S. Army Medical Acquisition Activity (USAMRAA), intends to award a sole source Firm-Fixed-Price contract to Magstim Inc. for the procurement of one Transcranial Magnetic Stimulation (TMS) chair for the Naval Medical Center San Diego (NMCSD). This contract is justified due to Magstim Inc.'s unique FDA-cleared TMS system, which meets specific clinical and operational requirements, including proprietary technology that aligns with Defense Health Agency (DHA) behavioral health protocols and offers superior pulse capacity. The TMS system is critical for treating resistant depression and OCD in military settings, ensuring compliance with HIPAA and DoD standards. Interested parties may direct inquiries to Christopher Cook at christopher.l.cook68.civ@health.mil, with the contract delivery expected by September 30, 2025, and the total contract value anticipated to be under $250,000.